BioregulatorResearch
Cardiogen
Also known as: Ala-Glu-Asp-Arg · AEDR
A tetrapeptide bioregulator for cardioprotection and myocardial recovery after heart failure or infarction.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
10 mg daily (oral, cycled)
Administration
Oral capsule
Mechanism of Action
Activates cardiac-specific gene expression to protect cardiomyocytes, reduce fibrosis, and support post-ischemic recovery.
Key Research Areas
bioregulatorheartcardiacmyocardial
Frequently Asked Questions
What is Cardiogen?▾
A tetrapeptide bioregulator for cardioprotection and myocardial recovery after heart failure or infarction.
How does Cardiogen work?▾
Activates cardiac-specific gene expression to protect cardiomyocytes, reduce fibrosis, and support post-ischemic recovery.
What is the recommended dosage for Cardiogen?▾
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Cardiogen?▾
The half-life of Cardiogen is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Cardiogen FDA approved?▾
Cardiogen is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Cardiogen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.